Artículos de revistas
Jnk And Ikkβ Phosphorylation Is Reduced By Glucocorticoids In Adipose Tissue From Insulin-resistant Rats
Registration in:
Journal Of Steroid Biochemistry And Molecular Biology. Elsevier Ltd, v. 145, n. , p. 1 - 12, 2015.
9600760
10.1016/j.jsbmb.2014.09.024
2-s2.0-84907856320
Author
Motta K.
Barbosa A.M.
Bobinski F.
Boschero A.C.
Rafacho A.
Institutions
Abstract
Objectives Peripheral insulin resistance (IR) is one of the main side effects caused by glucocorticoid (GC)-based therapies, and the molecular mechanisms of GC-induced IR are not yet fully elucidated. Thus, we aimed to investigate the effects of dexamethasone treatment on the main components of insulin and inflammatory signaling in the adipose tissue of rats. Materials/methods Male Wistar rats received daily injections of dexamethasone (1 mg/kg body weight (b.w.), intraperitoneally (i.p.)) for 5 days (DEX), whereas control rats received saline (CTL). The metabolic status was investigated, and the epididymal fat fragments were collected for lipolysis and western blot analyses. Results The DEX rats became hyperglycemic, hyperinsulinemic, insulin resistant and glucose intolerant, compared with the CTL rats (P < 0.05). The basal glycerol release in the fat fragments was 1.5-fold higher in the DEX rats (P < 0.05). The phosphorylation of protein kinase B (PKB) at ser473 decreased by 44%, whereas, the phosphorylation of insulin receptor substrate (IRS)-1 at ser307 increased by 93% in the adipose tissue of the DEX rats after an oral bolus of glucose (P < 0.05). The basal phosphorylation of c-jun-N-terminal kinase (JNK) and inhibitor of nuclear factor kappa-B (IKKβ) proteins was reduced by 46% and 58%, respectively, in the adipose tissue of the DEX rats (P < 0.05). This was paralleled with a significant reduction (47%) in the glucocorticoid receptor (GR) protein content in the adipose tissue of the DEX rats (P < 0.05). Conclusion The insulin-resistant status of rats induced by dexamethasone administration have PKB and IRS-1 activity attenuated in epididymal fat without increases in the phosphorylation of the proinflammatory signals JNK and IKKβ. 145
1 12 Baxter, J.D., Forsham, P.H., Tissue effects of glucocorticoids (1972) Am. J. Med., 53, pp. 573-589 Witchel, S.F., Defranco, D.B., Mechanisms of disease: Regulation of glucocorticoid and receptor levels - Impact on the metabolic syndrome (2006) Nat. Clin. Pract. Endocrinol. Metab., 11, pp. 621-631 Burén, J., Lai, Y.C., Lundgren, M., Eriksson, J.W., Jensen, J., Insulin action and signalling in fat and muscle from dexamethasone-treated rats (2008) Arch. Biochem. Biophys., 474, pp. 91-101 Burén, J., Liu, H.X., Jensen Eriksson, J.W., Dexamethasone impairs insulin signaling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes (2002) Eur. J. Endocrinol., 146, pp. 419-429 Shepherd, P.R., Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues (2005) Acta Physiol. Scand., 183, pp. 3-12 Coffer, P.J., Jin, J., Woodgett, J.R., Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation (1998) Biochem. J., 335, pp. 1-13 Lawlor, M.A., Alessi, D.R., PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? (2001) J. Cell Sci., 16, pp. 2903-2910 Chou, M.M., Hou, W., Johnson, J., Regulation of protein kinase C zeta by PI 3-kinase and PDK-1 (1998) Curr. Biol., 19, pp. 1069-1077 Sarbassov, D., Ali, S.M., Sabatini, D.M., Growing roles for the mTOR pathway (2005) Curr. Opin. Cell Biol., 7, pp. 596-603 Cohen, P., Alessi, D.R., Cross, D.A.E., PDKl, one of the missing links in insulin signal transduction? (2005) FEBS Lett., 410, pp. 3-10 Saltiel, A.R., Kahn, C.R., Insulin signalling and the regulation of glucose and lipid metabolism (2001) Nature, 414, pp. 799-806 Tsukumo, D.M., Carvalho-Filho, M.A., Carvalheira, J.B., Prada, P.O., Hirabara, S.M., Schenka, A.A., Araújo, E.P., Saad, M.J., Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance (2007) Diabetes, 56, pp. 1986-1998 Festa, A., D'Agostino, R., Jr., Williams, K., Karter, A.J., Mayer-Davis, E.J., Tracy, R.P., Haffner, S.M., The relation of body fat mass and distribution to markers of chronic inflammation (2001) Int. J. Obes. Relat. Metab. Disord., 25, pp. 1407-1415 Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.W., Long, J.M., Wynshaw-Boris, A., Karin, M., IKK-β links inflammation to obesity-induced insulin (2005) Nat. Med., 11, pp. 191-198 Medzhitov, R., Toll-like receptors and innate immunity (2001) Nat. Rev. Immunol., 1, pp. 135-145 Chen, L.W., Egan, L., Li, Z.W., Greten, F.R., Kagnoff, M.F., Karin, M., The two faces of IKK and NF-(B inhibition: Prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion (2003) Nat. Med., 9, pp. 575-581 Davis, R.J., Signal transduction by the JNK group of MAP kinases (2000) Cell, 103, pp. 239-252 Aguirre, V., Uchida, T., Yenush, L., Davis, R., White, M.F., Mechanisms of signal transduction: The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of ser 307 (2000) J. Biol. Chem., 275, pp. 9047-9054 Gao, Z., Hwang, D., Bataille, F., Lefevre, M., York, D., Quon, M.J., Ye, J., Mechanisms of signal transduction: Serine phosphorylation of insulin receptor substrate 1 (IRS-1) by inhibitor KappaB kinase (IKK) complex (2002) J. Biol. Chem., 277, pp. 48115-48121 Hussey, S.E., Liang, H., Costford, S.R., Klip, A., Defronzo, R.A., Sanchez-Avila, A., Ely, B., Musi, N., TAK-242, a small molecule inhibitor of toll-like receptor-4 signaling, unveils similarities and differences in lipopolysaccharide- and lipid-induced inflammation and insulin resistance in muscle cells (2013) Biosci. Rep., 33, pp. 37-47 Caperuto, L.C., Anhê, G.F., Amanso, A.M., Ribeiro, L.M., Medina, M.C., Souza, L.C., Carvalho, O.M., Carvalho, C.R., Distinct regulation of IRS proteins in adipose tissue from obese aged and dexamethasone-treated rats (2006) Endocrine, 29, pp. 391-398 Saklatvala, J., Glucocorticoids: Do we know how they work? (2002) Arthritis Res., 4, pp. 146-150 Kadmiel, M., Cidlowski, J.A., Glucocorticoid receptor signaling in health and disease (2013) Trends Pharmacol. Sci., 34, pp. 518-530 Funder, J.W., Glucocorticoid receptors (1992) J. Steroid Biochem. Mol. Biol., 43, pp. 389-394 Ray, A., Prefontaine, K.E., Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor (1994) Proc. Natl. Acad. Sci. U. S. A., 91, pp. 752-756 Yang-Yen, H.F., Chambard, J.C., Sun, Y.L., Smeal, T., Schmidt, T.J., Drouin, J., Karin, M., Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction (1990) Cell, 21, pp. 1205-1215 Oakley, R.H., Cidlowski, J.A., The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease (2013) J. Allergy Clin. Immunol., 132, pp. 1033-1044 Tornello, S., Orti, E., De Nicola, A.F., Rainbow, T.C., McEwen, B.S., Regulation of glucocorticoid receptors in brain by corticosterone treatment of adrenalectomized rats (1982) Neuroendocrinology, 35, pp. 411-417 Schacke, H., Docke, W.D., Asadullah, K., Mechanisms involved in the side effects of glucocorticoids (2002) Pharmacol. Ther., 96, pp. 23-43 Czock, D., Keller, F., Rasche, F.M., Häussler, U., Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids (2005) Clin. Pharmacokinet., 44, pp. 61-98 De Paula, F.M., Boschero, A.C., Carneiro, E.M., Bosqueiro, J.R., Rafacho, A., Insulin signaling proteins in pancreatic islets of insulin-resistant rats induced by glucocorticoid (2011) Biol. Res., 44, pp. 251-257 Lo, S., Russell, J.C., Taylor, A.W., Determination of glycogen in small tissue samples (1970) J. Appl. Physiol., 28, pp. 234-236 Rafacho, A., Giozzet, V.A., Bosqueiro, B.A.C., Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance (2008) Pancreas, 36, pp. 284-293 Rafacho, A., Quallio, S., Ribeiro, D.L., Taboga, S.R., Paula, F.M., Boschero, A.C., Bosqueiro, J.R., The adaptive compensations in endocrine pancreas from glucocorticoid-treated rats are reversible after the interruption of treatment (2010) Acta Physiol. (Oxford), 200, pp. 223-235 Nagajyothi, F., Kuliawat, R., Kusminski, C.M., Machado, F.S., Desruisseaux, M.S., Zhao, D., Schwartz, G.J., Tanowitz, H.B., Alterations in glucose homeostasis in a murine model of Chagas disease (2013) Am. J. Pathol., 182, pp. 886-894 Ferreira, D.S., Amaral, F.G., Mesquita, C.C., Barbosa, A.P., Lellis-Santos, C., Turati, A.O., Santos, L.R., Anhê, G.F., Maternal melatonin programs the daily pattern of energy metabolism in adult offspring (2012) PLoS One, 7, p. 38795 Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man (1985) Diabetologia, 28, pp. 412-419 Guerrero-Romero, F., Simental-Mendía, L.E., González-Ortiz, M., Martínez-Abundis, E., Ramos-Zavala, M.G., Hernández-González, S.O., Jacques-Camarena, O., Rodríguez-Morán, M., The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp (2010) J. Clin. Endocrinol. Metab., 95, pp. 3347-3351 Vaughan, M., The production and release of glycerol by adipose tissue incubated in vitro (1962) J. Biol. Chem., 237, pp. 3354-3358 Rafacho, A., Gonçalves-Neto, L.M., Ferreira, F.B., Protzek, A.O., Boschero, A.C., Nunes, E.A., Zoccal, D.B., Glucose homoeostasis in rats exposed to acute intermittent hypoxia (2013) Acta Physiol. (Oxford), 209, pp. 77-89 Rafacho, A., Abrantes, J.L., Ribeiro, D.L., Paula, F.M., Pinto, M.E., Boschero, A.C., Bosqueiro, J.R., Morphofunctional alterations in endocrine pancreas of short and long-term dexamethasone-treated rats (2011) Hormone Metab. Res., 43, pp. 275-281 Jocken, J.W., Blaak, E.E., Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity (2008) Physiol. Behav., 94, pp. 219-230 Espíndola-Antunes, D., Kater, C.E., Adipose tissue expression of 11beta-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity (2007) Arq. Bras. Endocrinol. Metab., 51, pp. 1397-1403 Nissen, R.M., Yamamoto, K.R., The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxyterminal domain (2000) Genes Dev., 14, pp. 2314-2329 Li, J., Zuo, L., Shen, T., Zhang, Z.N., Inhibition of the activation of transcriptional factor NFkappaB during sodium selenite-induced apoptosis in NB4 cells (2002) Zhongguo Shi Yan Xue Ye Xue Za Zhi, 10, pp. 409-412 Nunes, E.A., Gonçalves-Neto, L.M., Ferreira, F.B., Dos Santos, C., Fernandes, L.C., Boschero, A.C., Calder, P.C., Rafacho, A.F.B.D., Glucose intolerance induced by glucocorticoid excess is further impaired by co-administration with β-hydroxy-β-methylbutyrate in rats (2013) Appl. Physiol. Nutr. Metab., 38, pp. 1137-1146 Novelli, M., De Tata, V., Bombara, M., Lorenzini, A., Masini, M., Pollera, M., Bergamini, E., Masiello, P., Insufficient adaptive capability of pancreatic endocrine function in dexamethasone-treated ageing rats (1999) J. Endocrinol., 162, pp. 425-432 Thunhorst, R.L., Beltz, T.G., Johnson, A.K., Glucocorticoids increase salt appetite by promoting water and sodium excretion (2007) Am. J. Physiol. Regul. Integr. Comp. Physiol., 293, pp. 1444-1451 Caldefie-Chezet, F., Poulin, A., Tridon, A., Sion, B., Vasson, M.P., Leptin: A potential regulator of polymorphonuclear neutrophil bactericidal action? (2001) J. Leukocyte Biol., 69, pp. 414-418 Ortsäter, H., Sjöholm, A., Rafacho, A., Regulation of glucocorticoid receptor signaling and the diabetogenic effects of glucocorticoid excess (2012) State of the Art of Therapeutic Endocrinology, pp. 1-28. , S. Magdeldin, InTech Rijeka Rafacho, A., Gonçalves-Neto, L.M., Santos-Silva, J.C., Alonso-Magdalena, P., Merino, B., Taboga, S.R., Carneiro, E.M., Quesada, I., Pancreatic alpha-cell dysfunction contributes to the disruption of glucose homeostasis and compensatory insulin hypersecretion in glucocorticoid-treated rats (2014) PLoS One, 9, p. 93531 Ruzzin, J., Jensen, J., Contraction activates glucose uptake and glycogen synthase normally in muscles from dexamethasone-treated rats (2005) Am. J. Physiol. Endocrinol. Metab., 289, pp. 241-250 Paquot, N., Schneiter, P., Jéquier, E., Tappy, L., Effects of glucocorticoids and sympathomimetic agents on basal and insulin-stimulated glucose metabolism (1995) Clin. Physiol., 15, pp. 231-240 Franco-Colin, M., Tellez-Lopez, A.M., Quevedo-Corona, L., Racotta, R., Effects of long-term high-sucrose and dexamethasone on fat depots, liver fat, and lipid fuel fluxes through the retroperitoneal adipose tissue and splanchnic area in rats (2000) Metabolism, 49, pp. 1289-1294 Slavin, B.G., Ong, J.M., Kern, P.A., Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes (1994) J. Lipid Res., 35, pp. 1535-1541 Mokuda, O., Sakamoto, Y., Ikeda, T., Mashiba, H., Sensitivity and responsiveness of glucose output to insulin in isolated perfused liver from dexamethasone-treated rats (1991) Hormone Metab. Res., 23, pp. 53-55 Saad, M.J., Folli, F., Kahn, J.A., Kahn, C.R., Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats (1993) J. Clin. Invest., 92, pp. 2065-2072 Nicastro, H., Gualano, B., De Moraes, W.M., De Salles Painelli, V., Da Luz, C.R., Dos Santos Costa, A., De Salvi Guimarães, F., Lancha, A.H., Jr., Effects of creatine supplementation on muscle wasting and glucose homeostasis in rats treated with dexamethasone (2012) Amino Acids, 42, pp. 1695-1701 Cai, D., Yuan, M., Frantz, D.F., Melendez, P.A., Hansen, L., Lee, J., Shoelson, S.E., Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB (2005) Nat. Med., 11, pp. 183-190 Shoelson, S.E., Lee, J., Goldfine, A.B., Inflammation and insulin resistance (2006) J. Clin. Invest., 116, pp. 1793-1801 Fransson, L., Dos Santos, C., Wolbert, P., Sjöholm, A., Rafacho, A., Ortsäter, H., Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome (2014) Diabetol. Metab. Syndrome, 6, pp. 1-13 Wang, X.A., Zhang, R., Zhang, S., Deng, S., Jiang, D., Zhong, J., Yang, L., Li, H., Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance (2013) Am. J. Physiol. Endocrinol. Metab., 305, pp. 485-495 Haasch, D., Berg, C., Clampit, J.E., Pederson, T., Frost, L., Kroeger, P., Rondinone, C.M., PKCtheta is a key player in the development of insulin resistance (2006) Biochem. Biophys. Res. Commun., 343, pp. 361-368 Wang, C., Liu, M., Riojas, R.A., Xin, X., Gao, Z., Zeng, R., Wu, J., Liu, F., Protein kinase C q (PKCq)-dependent phosphorylation of PDK1 at ser 504 and ser 532 contributes to palmitate-induced insulin resistance (2009) J. Biol. Chem., 284, pp. 2038-2044 Morgan, S.A., Sherlock, M., Gathercole, L.L., Lavery, G.G., Lenaghan, C., Bujalska, I.J., Laber, D., Tomlinson, J.W., 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle (2009) Diabetes, 58, pp. 2506-2515 Sapolsky, R.M., Krey, C., McEwen, B.S., Stress down-regulates corticosterone receptors in a site-specific manner in the brain (1984) Endocrinology, 114, pp. 287-292 Svec, F., Rudis, M., Glucocorticoids regulate the glucocorticoid receptor in the AtT-20Cell (1981) J. Biol. Chem., 256, pp. 5984-5987